https://public.com/stocks/alny/pe-ratio
Alnylam Pharmaceuticals (ALNY) P/E Ratio: Current & Historical Analysis
The P/E ratio of Alnylam Pharmaceuticals (ALNY) is 69.72 as of May 14, 2026. Track historical trends, assess valuation, and make informed investing decisions...
p ealnylampharmaceuticalsratiocurrent
https://www.financialcontent.com/quote/NQ:ALNY/competitors
Competitors for Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) | FinancialContent
common stockcompetitorsalnylampharmaceuticalsinc
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/market-sentiment-around-loss-making-alnylam-pharmaceuticals-1
Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Simply Wall St...
We feel now is a pretty good time to analyse Alnylam Pharmaceuticals, Inc.'s ( NASDAQ:ALNY ) business as it appears the...
https://lician.com/institutional/alny
ALNY Institutional Ownership - Hedge Fund & Mutual Fund Holdings | Lician
ALNY institutional ownership data. See which hedge funds, mutual funds, and institutions own ALNY stock. Track 13F filings and ownership changes.
institutional ownershiphedge fundalnymutualholdings